Kinra 250mg Tablets is primarily indicated in conditions like Cervicitits, Lower respiratory tract infections, Multiple myeloma, Otitis media, Reversal of excessive bradycardia, Rtis; otitis media, Skin and soft tissue infections, Soft tissue and skin infections, Status epilepticus (unlicensed use), Upper respiratory tract infections, Urethritis.
Kinra 250mg Tablets is contraindicated in conditions like Hypersensitivity, Hepatic impairment.
The severe or irreversible adverse effects of Kinra 250mg Tablets, which give rise to further complications include Pseudomembranous colitis, Jaundice, Maculopapular rash, Cholestasis.Kinra 250mg Tablets produces potentially life-threatening effects which include Anaphylaxis, Angioneurotic edema, which are responsible for the discontinuation of Kinra 250mg Tablets therapy. The signs and symptoms that are produced after the acute overdosage of Kinra 250mg Tablets include Severe vomiting, Severe diarrhea, severe nausea, Hearing loss. The symptomatic adverse reactions produced by Kinra 250mg Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Dizziness, Vertigo, Headache, Fatigue, Nausea, Vomiting, Diarrhea, Palpitation, Abdominal pain, Rashes, Photosensitivity, Deafness, GI disturbance.
Kinra 250mg Tablets should be used with caution in patients with illness or any allergy, especially allergies to drugs, liver disease, jaundice, history of colitis or stomach problems or kidney disease. This drug should be used only if clearly needed during pregnancy or lactation.